AXSM
Axsome Therapeutics Inc
193.50$
-4.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +478.3% | +107.8% | +15.0% | -23.7% | +108.2% | -2.2% | +5,692.1% | +55.2% | +16.4% | +13.9% | |
| – | +113.2% | +152.9% | +2.0% | -15.3% | +248.4% | +141.3% | +41.0% | +81.3% | +66.0% | +36.1% | +10.0% | |
| – | +12.6% | -46.9% | +33.8% | -138.1% | – | +161.7% | +30.0% | +91.8% | – | – | – | |
| – | +82.2% | +305.2% | -120.0% | – | +895.8% | -97.3% | -21.4% | +7,205.6% | -219.9% | – | -166.4% | |
| – | +0.0% | +417.8% | -90.5% | +230.3% | -50.7% | +184.7% | +571.2% | +127.9% | -17.1% | -53.6% | +77.8% | |
| – | +0.0% | +417.8% | -90.5% | +230.3% | -50.7% | +184.7% | +571.2% | +17,335.7% | -98.9% | -53.6% | +77.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +893,020.0% | -99.9% | +73,051.5% | -44.6% | +1,689.2% | -93.7% | -101.2% | +202.7% | +245.0% | – | – | |
| – | +41.5% | +36.2% | -102.8% | +1,109.4% | – | +113.4% | -101.1% | – | +88.9% | -101.2% | +315.4% | |
| – | +931.5% | -81.1% | +139.6% | -58.0% | +2,415.3% | -83.2% | -73.8% | +2,456.9% | +16.3% | -82.5% | +75.4% | |
| – | +8,470.0% | -125.1% | – | – | – | -117.5% | – | – | +62.1% | -138.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.